Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06506214
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Cross-sectional Multicenter Study Aimed at Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ADlupus
Brief Summary:
This multicenter study aims to evaluate treatment adherence and satisfaction of patients with cutaneous lupus influenced by perception of the disease fear of side effects cost of medications and the doctor-patient relationship Adherence will be measured by a VAS of 80 or higher on the Medical Adherence Self-Report Inventory scale
Detailed Description:
This multicenter cross-sectional study aims to characterize adherence to treatment and satisfaction of patients with cutaneous lupus Non-adherence to treatment is a major problem influenced by perception of the disease fear of adverse effects cost of medications and the doctor-patient relationship Adherence will be measured by a VAS of 80 or more on the visual analog scale of the Medical Adherence Self-Report Inventory questionnaire
The study is descriptive multicenter and cross-sectional Participants will be adult patients suffering from cutaneous lupus diagnosed by a dermatologist and under treatment able to complete questionnaires Patients with systemic lupus cognitive or psychiatric disorders will be excluded from the study
The inclusion period is two years with 30 minutes of follow-up per participant The study will provide a better understanding of the feelings of patients with cutaneous lupus and the factors limiting their adherence to treatment
The study is descriptive multicenter and cross-sectional Participants will be adult patients suffering from cutaneous lupus diagnosed by a dermatologist and under treatment able to complete questionnaires Patients with systemic lupus cognitive or psychiatric disorders will be excluded from the study
The inclusion period is two years with 30 minutes of follow-up per participant The study will provide a better understanding of the feelings of patients with cutaneous lupus and the factors limiting their adherence to treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None